Acorda Therapeutics, Inc. logo

Acorda Therapeutics, Inc.

NASDAQ:ACOR

Overview | Financials
Company Name Acorda Therapeutics, Inc.
Symbol ACOR
Currency USD
Price 0.661
Market Cap 821,028
Dividend Yield 0%
52-week-range 0.612 - 24.2
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Ron Cohen M.D.
Website https://www.acorda.com

An error occurred while fetching data.

About Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets

Related Stocks

Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc.

EVFM

0.07 USD

Financials

Numbers are in millions USD

Numbers are in millions USD